Literature DB >> 21098015

Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation.

Tomohiro Mizuno1, Masashi Mizuno, B Paul Morgan, Yukihiro Noda, Kiyofumi Yamada, Noriko Okada, Yukio Yuzawa, Seiichi Matsuo, Yasuhiko Ito.   

Abstract

BACKGROUND: The peritoneal cavity is isolated from the outside and is usually a sterile environment. Patients on peritoneal dialysis (PD) have PD fluid (PDF) infused into the peritoneal cavity. We previously showed that unregulated complement activation could contribute to the development of peritoneal inflammation in yeast peritonitis in PD therapy. In that situation, suppression of local complement activation is essential to protect the host from further injury. The membrane complement regulators (CRegs), Crry, CD55 and CD59, are expressed in the rat peritoneum, especially along the mesothelial cell layer.
METHODS: We investigated CRegs' functional roles in the peritoneal cavity using blocking mAb against each CReg and complement activation in different PDFs.
RESULTS: Blockade of any single CReg did not cause spontaneous peritoneal injury in rat. Combined blockade of Crry and CD59 induced focal peritoneal tissue injury and heavy accumulation of inflammatory cells with peritoneal edema at 24 h. Deposits of C3 and C5b-9 were found on the peritoneal surface after combined blocking of Crry and CD59. Systemic complement depletion by cobra venom factor abrogated these inflammatory changes. When combined blockade of Crry and CD59 was performed with PDF of different pH and glucose concentration in rats, the peritoneal injuries were enhanced with lower pH and higher glucose concentration. These results were confirmed by in vitro experiments using primary rat mesothelial cell culture.
CONCLUSIONS: Rat CRegs, Crry and CD59, specifically collaborate to control complement activation in rat peritoneum. During PD, impairment of CReg might contribute to the development of severe peritoneal inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098015     DOI: 10.1093/ndt/gfq683

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Soluble CD59 in peritoneal dialysis: a potential biomarker for peritoneal membrane function.

Authors:  Bernardo Faria; Mariana Gaya da Costa; Carla Lima; Loek Willems; Ricardo Brandwijk; Stefan P Berger; Mohamed R Daha; Manuel Pestana; Marc A Seelen; Felix Poppelaars
Journal:  J Nephrol       Date:  2020-12-11       Impact factor: 3.902

2.  Transcriptional patterns in peritoneal tissue of encapsulating peritoneal sclerosis, a complication of chronic peritoneal dialysis.

Authors:  Fabian R Reimold; Niko Braun; Zsuzsanna K Zsengellér; Isaac E Stillman; S Ananth Karumanchi; Hakan R Toka; Joerg Latus; Peter Fritz; Dagmar Biegger; Stephan Segerer; M Dominik Alscher; Manoj K Bhasin; Seth L Alper
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

3.  High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Keiko Higashide; Yumi Sei; Daiki Iguchi; Fumiko Sakata; Masanobu Horie; Shoichi Maruyama; Seiichi Matsuo; B Paul Morgan; Yasuhiko Ito
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

Review 4.  The Complement System in Dialysis: A Forgotten Story?

Authors:  Felix Poppelaars; Bernardo Faria; Mariana Gaya da Costa; Casper F M Franssen; Willem J van Son; Stefan P Berger; Mohamed R Daha; Marc A Seelen
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

5.  Alteration of membrane complement regulators is associated with transporter status in patients on peritoneal dialysis.

Authors:  Daniel Kitterer; Dagmar Biegger; Stephan Segerer; Niko Braun; M Dominik Alscher; Joerg Latus
Journal:  PLoS One       Date:  2017-05-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.